Quick Takeaways
- Vlad Coric has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $315,562,441.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Vlad Coric
- Location
- New Haven, CT
- Summary
- The estimated net worth of Vlad Coric is at least $315,562,441 dollars as of 03 Mar 2026. Vlad Coric is the Chief Executive Officer, Director of Biohaven Pharmaceutical Holding Co Ltd. and owns shares of Biohaven Pharmaceutical Holding Co Ltd. stock worth about $274.21M. Vlad Coric is the Chief Executive Officer, Director of Biohaven Ltd. and owns shares of Biohaven Ltd. (BHVN) stock worth about $41.01M. Vlad Coric is the Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $345K.
- Signature
- /s/ George Clark, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Vlad Coric and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Biohaven Pharmaceutical Holding Co Ltd. ($274,211,637).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Vlad Coric
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | $274,211,637 | 03 Oct 2022 | ||
| BHVN | Biohaven Ltd. | Chief Executive Officer, Director | $41,005,808 | +$4,999,995 | +14% | 27 Feb 2026 |
| RPRX | Royalty Pharma plc | Director | $344,996 | 13 May 2025 | ||
| RVNC | Revance Therapeutics, Inc. | Director | $0 | 04 Feb 2025 | ||
| AKLI | Social Capital Suvretta Holdings Corp. I | Director | 29 Jun 2021 | |||
| MANE | Veradermics, Inc | Director | 03 Feb 2026 |
Insider Transactions Reported by Vlad Coric:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.